Influenza B Virus: From Infection to Prevention
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".
Deadline for manuscript submissions: 30 May 2027 | Viewed by 1994
Editor
Interests: influenza drug susceptibility monitoring; virus fitness; preclinical models for infection; antiviral development
Special Issue Information
Dear Colleagues,
Influenza A (IAV) and B (IBV) viruses co-circulate yearly during seasonal epidemics. IBV causes about a quarter of all influenza cases in an average season. Both influenza types cause severe respiratory illnesses in humans. IAV significantly affects young children and the elderly, while the burden of IBV infections is especially high among school-aged children in terms of incidence, hospitalization, and fatal outcomes, with the underlying pathogenic mechanisms remaining unclear. The primary treatment for influenza, Neuraminidase inhibitors (NAIs), are less effective against IBV compared to IAV. In the 21st century, two lineages of IBV, B/Victoria and B/Yamagata, have been co-circulating. After non-pharmaceutical interventions that were introduced during the COVID-19 pandemic, B/Yamagata lineage viruses have not been detected. Less research has been conducted on IBV than on IAV, as IBV lacks an established animal reservoir and pandemic potential. However, this also means that IBV infections and transmissions could be controlled well by broadly protective vaccines.
The objective of this Special Issue is to collect articles (research articles, short communications, reviews, and commentaries) that focus on surveillance, advancing knowledge about IBV epidemiology, evolution, antigenicity, pathogenesis, and immunity, as well as suitable animal models for infection, which is critical for the development of seasonal influenza vaccines and novel treatment strategies.
Dr. Saira Hussain
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza B viruses
- epidemiology
- evolution
- pathogenesis
- immunity
- vaccine
- antivirals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
